March 2015: Puridify awarded Industrial Biotechnology Catalyst project

innovate-uk-logoInnovateUK CatalystUCLEPSRCBBSRC

Puridify was successful leading this application for a £2,354,840 Industrial Research project from Innovate UK’s Industrial Biotechnology Catalyst program. This will see Puridify and University College London carry out the industrial validation of the nanofibre platform technology for biotherapeutic manufacture driving forward the technology’s commercialisation. This work is co-funded by the Engineering and Physical Sciences Research Council (EPSRC) and the Biotechnology and Biological Sciences Research Council (BBSRC).

May 2014: Imperial Innovations and SR One lead £850,000 seed financing for Puridify

InnovationsImperial Innovations Group plc (AIM:IVO, ‘Innovations’), the leading technology commercialisation and investment company and S.R.One Ltd, GlaxoSmithKline’s venture capital fund, announce today that they have led, alongside co-investor UCL Business PLC (UCLB), an £850,000 seed financing for Puridify, a newly formed company providing purification solutions for biotherapeutic manufacturing.

April 2014: Puridify’s successful Collaborative R&D award program application

TSBCollaborativeR&DUCLBBSRC

Puridify was successful leading this application for a £499,728 Technology-inspired innovation – Biosciences project from the Technology Strategy Board’s Collaborative R&D award program. This will see Puridify and University College London develop and test its platform technology with a series of scale down prototypes with key end users driving forward the technology’s commercialisation. This work is co-funded by the Biotechnology and Biological Sciences Research Council.